New potent, short-linker BODIPY-630/650™ labelled fluorescent adenosine receptor agonists

MedChemComm

Volumn 3, Issue 3, 2012, Pages 333-338

  Dale, Clare L ^a   Hill, Stephen J ^a   Kellam, Barrie ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; FLUORESCENT DYE;

ARTICLE; CHEMICAL LABELING; CHEMICAL STRUCTURE; CHO CELL; CONJUGATION; DRUG SYNTHESIS; HUMAN; HUMAN CELL; INCUBATION TIME; LIGAND BINDING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 84857763898     PISSN: 20402503     EISSN: 20402511     Source Type: Journal    
DOI: 10.1039/c2md00247g     Document Type: Article

References (25)

1. S. R. George B. F. O'Dowd S. P. Lee Nat. Rev. Drug Discovery 2002 1 809
2. V. Ralevic G. Burnstock Pharmacol. Rev. 1998 50 413
3. B. B. Fredholm A. P. IJzermann K. A. Jacobson K.-N. Klotz J. Linden Pharmacol. Rev. 2001 53 527
4. K. A. Jacobson Z.-G. Gao Nat. Rev. Drug Discovery 2006 5 247
5. M. E. Olah G. L. Stiles Annu. Rev. Pharmacol. 1995 21 581
6. R. A. Olsson J. D. Pearson Physiol. Rev. 1990 70 761
7. R. J. Middleton B. Kellam Curr. Opin. Chem. Biol. 2005 9 517
8. M. Leopoldo E. Lacivita F. Berardi R. Perrone Drug Discov. Today 2009 14 706
9. S. J. Briddon R. J. Middleton F. M. Flavin J. A. Weinstein M. W. George B. Kellam S. J. Hill Proc. Natl. Acad. Sci. U. S. A. 2004 101 4673
10. S. J. Briddon R. J. Middleton A. J. Yates M. W. George B. Kellam S. J. Hill Faraday Discuss. 2004 122 197
11. M. Macchia F. Salvetti S. Barontini F. Calvani M. Gesi M. Hamdan A. Lucacchini A. Pellegrini P. Soldani C. Martini Bioorg. Med. Chem. Lett. 1998 8 3223
12. M. Macchia F. Salvetti S. Bertini V. Di Bussolo L. Gattuso M. Gesi M. Hamdan K. N. Klotz T. Laragione A. Lucacchini F. Minutolo S. Nencetti C. Papi D. Tuscano C. Martini Bioorg. Med. Chem. Lett. 2001 11 3023 3026
13. R. J. Middleton S. J. Briddon Y. Cordeaux A. S. Yates C. L. Dale M. W. George J. G. Baker S. J. Hill B. Kellam J. Med. Chem. 2007 50 782
14. J. G. Baker R. Middleton L. Adams L. T. May S. J. Briddon B. Kellam S. J. Hill Br. J. Pharmacol. 2010 159 772
15. H. C. Kang and R. P. Haugland, United States Patent, 1995, US 5,451,663
16. A. Furstner T. Gastner H. Weintritt J. Org. Chem. 1999 64 2221
17. N. Engel W. Steglich Angew. Chem., Int. Ed. Engl. 1978 17 676
18. R. Ketcham D. Jambotkar L. Martinelli J. Org. Chem. 1962 27 4666
19. R. A. Jones T. Pojarlieva R. J. Head Tetrahedron 1967 24 2013 2017
20. N. Meltola and A. Soini, United States Patent, 2010, US 7,763,439 B2
21. J. G. Baker S. J. Hill J. Pharmacol. Exp. Ther. 2007 320 218
22. Y. Cordeaux S. J. Briddon A. E. Megson J. McDonnell J. M. Dickenson S. J. Hill Mol. Pharmacol. 2000 58 1075
23. Y. Cordeaux A. P. IJzerman S. J. Hill Br. J. Pharmacol. 2004 143 705 714
24. Y. Cheng W. H. Prusoff Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (IC50) of an enzymatic reaction Biochem. Pharmacol. 1973 22 3099 3108
25. R. Narlawar J. R. Lane M. Doddareddy J. Lin J. Brussee A. P. IJzerman J. Med. Chem. 2010 53 3028 3037